Scientific Opinion on the substantiation of a health claim related to pantothenic acid and contribution to normal energy‐yielding metabolism pursuant to Article 14 of Regulation (EC) No 1924/2006

Abstract

Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to pantothenic acid and contribution to normal energy‐yielding metabolism. The food constituent, pantothenic acid, which is the subject of the health claim, is sufficiently characterised. Contribution to normal energy‐yielding metabolism is a beneficial physiological effect for infants and young children. A claim on pantothenic acid and normal energy‐yielding metabolism in the general population has already been assessed with a favourable outcome. The Panel notes that the role of pantothenic acid in normal energy‐yielding metabolism applies to all ages, including infants and young children (from birth to three years). The Panel concludes that a cause and effect relationship has been established between the dietary intake of pantothenic acid and contribution to normal energy‐yielding metabolism.